Daniel Ying

Executive Director·OrbiMed

Shanghai, China

Bio

Professional summary

Daniel Ying is an Executive Director on OrbiMed's Asia team and joined the firm in 2018. Before OrbiMed, he was an Assistant Vice President at C-Bridge Capital focused on pharmaceutical and biotech investments and previously worked at IMS Consulting Group, now part of IQVIA. He received bachelor's and master's degrees in Chemistry from Tsinghua University.

Background

Career, education, and skills

Career history

OrbiMedExecutive Director2018 – Present
C-Bridge CapitalAssistant Vice President
IMS Consulting GroupConsulting

Education

Tsinghua UniversityBachelor's degree in Chemistry
Tsinghua UniversityMaster's degree in Chemistry

Other partners at OrbiMed

12 more profiles

View firm →

Aditya Tolia

Private Equity Senior Analyst

OrbiMed

Private Equity Senior Analyst at OrbiMed with prior Investec and PwC banking experience.

Financial modelingHealthcare investingInvestment bankingM&APrivate equity

Alexis Megibow

Private Equity Associate

OrbiMed

Private Equity Associate at OrbiMed.

Healthcare investingPrivate equityVenture capital

Ankesh Bhansali

Managing Director

OrbiMed

OrbiMed Asia Managing Director focused on healthcare private equity.

Asia healthcareCapital marketsHealthcare deliveryHealthcare private equityM&APharmaceuticals

Arun Sadhanandham

Managing Director

OrbiMed

OrbiMed Asia Managing Director investing in healthcare private equity.

Asia healthcareHealthcare deliveryHealthcare private equityInvestment bankingMedical devicesPharmaceuticals

Brendan Weber, CFA

Principal

OrbiMed

Principal on OrbiMed's Credit & Royalty team focused on structured credit and royalty financings.

Healthcare creditMedical devicesPharmaceuticalsRoyalty-based financingStructured credit

Carl Gordon

Managing Partner

OrbiMed

OrbiMed Managing Partner leading private equity and biotech company formation.

BiotechnologyBoard governanceCompany formationHealthcare private equityInnovative therapeuticsLife sciences

Carl L. Gordon

Managing Partner

OrbiMed

Carl L. Gordon is a Managing Partner at OrbiMed and leads the firm's private equity team.

Life-sciences private equityTherapeuticsVenture investing

Carter Neild

Managing Partner

OrbiMed

OrbiMed Managing Partner focused on healthcare royalties and Asia private investments.

Asia private investmentsHealthcare private equityHealthcare royaltiesInvestment managementStructured healthcare finance

Clay Daniel DeMarcus

Principal

OrbiMed

Principal focused on medical technology and non-therapeutics venture investing.

Healthcare equity researchHealthcare investment bankingMedical technologyNon-therapeuticsVenture-stage investing

Cooper Steputis

Private Equity / Venture Capital

OrbiMed

Healthcare private equity and venture investor with prior investment banking experience.

Healthcare venture capitalInvestment bankingMolecular biologyNeurosciencePrivate equity

David Bonita

General Partner

OrbiMed

OrbiMed General Partner and physician-investor in healthcare and therapeutics.

BiotechnologyBoard governanceHealthcare investingMedical devicesOncologyTherapeutics

David Wang

Partner

OrbiMed

OrbiMed Asia Partner focused on Greater China healthcare investments.

BiotechnologyDiagnostic imagingGreater China healthcareHealthcare private equityMedical diagnosticsPersonalized medicine

See something out of date?

Suggest a correction — our team reviews every edit.

Improve this profile